Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medingo’s new president and CEO to set up US operations

This article was originally published in Clinica

Executive Summary

Medingo (Yoqneam, Israel), a company that is about to launch its first product – an innovative insulin dispenser in the form of a skin patch plus remote control to direct levels of insulin delivered – has made Pete Wehrly president and CEO. He will also lead the setting up of operations in the US, replacing Ofer Yodfat in that role. Dr Yodfat will continue as general manager of Medingo Israel. Mr Wehrly is a veteran Medtronic executive with more than 20 years’ experience in the industry. Before joining the company, he was senior vice-president and president of Medtronic’s spinal and biologics division. The company has also appointed Kim Stebbings as vice-president of marketing. Ms Stebbings joins from Florida-based Anodyne Therapy (infrared light therapy) where she was vice-president of sales and marketing. She has more than 20 years’ experience as a medical technology sales and marketing executive.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043403

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel